| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ocular Therapeutix, Inc. (OCUL) has 9 insiders with recent SEC Form 4 filings, including 10 buys and 1 sell. OCUL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 394.7K | $3.94M | - | |
| Other | 389.3K | $3.88M | - | |
| Other | 330.7K | $3.30M | - | |
| Other | 326.3K | $3.25M | - | |
| Other | 323.4K | $3.22M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2018 | Mattessich Antony C.47 | President And CEO | Buy | 16,900 | $6.23 | $105,287.00 | +80.5% | |
| Dec 12, 2017 | Mattessich Antony C.47 | President And C.e.o. | Buy | 21,000 | $4.29 | $90,090.00 | New | |
| Dec 7, 2017 | Notman Donald | Chief Financial Officer | Buy | 4,800 | $4.00 | $19,200.00 | New | |
| Dec 6, 2017 | Bollag Daniel M | See Remarks | Buy | 24,700 | $3.93 | $97,071.00 | New | |
| Nov 16, 2017 | Sawhney Amarpreet | Exec. Chairman Of The Board | Buy | 19,000 | $5.18 | $98,420.00 | +2.8% | |
| Dec 15, 2016 | Sawhney Amarpreet | President And CEO | Buy | 45,300 | $7.85 | $355,605.00 | +7.2% | |
| Jun 9, 2016 | Sawhney Amarpreet | President And CEO | Buy | 10,000 | $6.70 | $67,000.00 | +1.8% | |
| Nov 17, 2015 | Sawhney Amarpreet | President And CEO | Buy | 10,000 | $8.25 | $82,500.00 | +1.8% | |
| Sep 15, 2015 | Fortune James | Chief Operating Officer | Sell | 9,470 | $17.16 | $162,505.20 | -7.8% | |
| Sep 14, 2015 | Sawhney Amarpreet | President And CEO | Buy | 15,000 | $16.50 | $247,456.32 | +1.4% |